SGLT2i Improves Outcomes After TAVI

[ad_1]

(MedPage Today) — CHICAGO — Dapagliflozin (Farxiga) lowered mortality and heart failure worsening in high-risk older adults getting transcatheter aortic valve implantation (TAVI), the DapaTAVI trial showed.
In a population with a history of…

[ad_2]

Source link : https://www.medpagetoday.com/meetingcoverage/acc/114884

Author :

Publish date : 2025-03-29 18:43:00

Copyright for syndicated content belongs to the linked Source.